# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-268215
Filing Date
2019-10-16
Accepted
2019-10-16 11:55:14
Documents
10
Period of Report
2019-12-05
Effectiveness Date
2019-10-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d805243ddef14a.htm | DEF 14A | 774643
2 | GRAPHIC | g805243dsp-088.jpg | GRAPHIC | 181874
3 | GRAPHIC | g805243dsp-089.jpg | GRAPHIC | 269728
4 | GRAPHIC | g805243dsp03.jpg | GRAPHIC | 1727
5 | GRAPHIC | g805243dsp26.jpg | GRAPHIC | 21121
6 | GRAPHIC | g805243dsp27.jpg | GRAPHIC | 27237
7 | GRAPHIC | g805243dsp28.jpg | GRAPHIC | 30549
8 | GRAPHIC | g805243dsp28a.jpg | GRAPHIC | 22308
9 | GRAPHIC | g805243dsp31.jpg | GRAPHIC | 25989
10 | GRAPHIC | g805243dsp32.jpg | GRAPHIC | 19868
| Complete submission text file | 0001193125-19-268215.txt |  | 1603698

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 191152282
SIC: 2835 In Vitro & In Vivo Diagnostic Substances